PRISM BioLab Co.,LTD (206A.T)

JPY 292.0

(-1.68%)

Annual Cash Flows

(In JPY)
Breakdown 2023 2022
Operating Cash Flow -513.81 Million 102.96 Million
Net Income -525.7 Million 74.15 Million
Depreciation & Amortization 8.73 Million 1.2 Million
Deferred income taxes - -
Stock-based compensation - -
Change in working capital -19.86 Million 33.43 Million
Other non-cash items -4.18 Million 1.24 Million
Investing Cash Flow -40.37 Million -7.87 Million
Investments in PPE -34.59 Million -5.71 Million
Acquisitions - -
Investment purchases - -
Sales/Maturities of investments - -
Other Investing Activities -5.78 Million -2.15 Million
Financing Cash Flow - 110.87 Million
Debt repayment - -
Dividends payments - -
Common Stock Repurchased - -
Common Stock Issuance - 210.87 Million
Other Financing Activities - -100 Million
Accounts receivables 21.72 Million -
Accounts payables - -
Inventory - -
Other working capital -41.58 Million -
Cash at beginning of period 1.68 Billion 1.47 Billion
Cash at end of period 1.13 Billion 1.68 Billion
Capital Expenditure -34.59 Million -5.71 Million
Effect of forex changes on cash 138 Thousand 10.48 Million
Net cash flow / Change in cash -554.05 Million 216.44 Million
Free Cash Flow -548.4 Million 97.24 Million

Cash Flow Charts